Identification and quantification of concentration-dependent biomarkers in MCF-7/BOS cells exposed to 17β-estradiol by 2-D DIGE and label-free proteomics

Journal of Proteomics

Volumn 75, Issue 14, 2012, Pages 4555-4569

  Collodoro, Mike ^a   Lemaire, Pascale ^a   Eppe, Gauthier ^a   Bertrand, Virginie ^a   Dobson, Rowan ^a   Mazzucchelli, Gabriel ^a   Widart, Joëlle ^a   De Pauw, Edwin ^a   De Pauw Gillet, Marie Claire ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

17 Estradiol; 2 D DIGE; Label free; MCF 7 BOS; SRM; Xenoestrogens

Indexed keywords

BIOLOGICAL MARKER; COUMESTROL; CYTOKERATIN 2; DAIDZEIN; ENTEROLACTONE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 74; PHYTOESTROGEN; RESVERATROL; TAMOXIFEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EF1; TRANSCRIPTION FACTOR EF2; TRANSCRIPTION FACTOR FKBP4; TRANSCRIPTION FACTOR GDIB; TRANSCRIPTION FACTOR K2C8; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION;

BIOLOGICAL MARKERS; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESTRADIOL; HUMANS; NEOPLASMS, EXPERIMENTAL; PEPTIDE MAPPING; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STAINING AND LABELING;

ANIMALIA;

EID: 84863822891     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.04.032     Document Type: Article

References (63)

1. Mortensen A., Arukwe A. Dimethyl sulfoxide is a potent modulator of estrogen receptor isoforms and xenoestrogen biomarker responses in primary culture of salmon hepatocytes. Aquat Toxicol 2006, 103:79-99.
2. Takahashi A., Higashitani T., Yakou Y., Saitou M., Tamamoto H., Tanaka H. Evaluating bioaccumulation of suspected endocrine disruptors into periphytons and benthos in the Tama River. Water Sci Technol 2003, 47:71-76.
3. Sharpe M., Irvine S. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health?. BMJ 2004, 328:447-451.
4. Mantovani A., Maranghi F., La Rocca C., Tiboni G., Clementi M. The role of toxicology to characterize biomarkers for agrochemicals with potential endocrine activities. Reprod Toxicol 2008, 26:1-7.
5. Rudel R., Perovich L. Endocrine disrupting chemicals in indoor and outdoor air. J Atmos Environ 2009, 243:170-181.
6. Barrett J. Endocrine disruptors: estrogens in a bottle?. Environ Health Perspect 2009, 6:117-241.
7. Rhind S.M. Endocrine disrupting compounds and farm animals: their properties, actions and routes of exposure. Domest Anim Endocrinol 2002, 23:179-187.
8. Sweeney T. Is exposure to endocrine disrupting compounds during fetal/post-natal development affecting the reproductive potential of farm animals?. Domest Anim Endocrinol 2002, 23:203-209.
9. Magnusson U. Can farm animals help to study endocrine disruption?. Domest Anim Endocrinol 2005, 29:430-435.
10. Borget C., LaKind J., Witorsh R. A critical review of methods for comparing estrogenic activity of endogenous and exogenous chemicals in human milk and infant formula. Environ Health Perspect 2003, 111:1020-1036.
11. Patisaul H., Adewale H. Long-term effects of environmental endocrine disruptors on reproductive physiology and behaviour. Front Behav Neurosci 2009, 3:10.
12. Rhind S.M., Kyle C.E., Mackies C., Yates K., Duff E.I. Geographic variation in tissue accumulation of endocrine disrupting compounds (EDCs) in grazing sheep. J Environ Pol 2011, 159:416-422.
13. Black R.M., Muir B. Derivatisation reactions in the chromatographic analysis of chemical warfare agents and their degradation products. J Chromatogr 2003, 1000:253-281.
14. Fine D.D., Breidenbach G.P., Price T.L., Hu Tchins S.R. Quantitation of estrogens in ground water and swine lagoon samples using solid-phase extraction, pentafluorobenzyl/trimethylsilyl derivatizations and gas chromatography-negative ion chemical ionization tandem mass spectrometry. J Chromatogr A 2003, 1017:167-185.
15. Biddle S., Teale P., Robinson A., Bowman J., Houghton E. Gas chromatography-mass spectrometry/mass spectrometry analysis to determine natural and post-administration levels of oestrogens in bovine serum and urine. Anal Chim Acta 2007, 586:115-121.
16. Soto A., Sonnenschein C., Chung K., Fernandez M., Olea N., Serrano F. The E-screen assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 1995, 103:113-122.
17. Bolger R., Wiese T., Ervin K., Nestich S., Checovich W. Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ Health Perspect 1998, 106:551-557.
18. Lancova K., Dip R., Antignac J.-P., Le Bizec B., Elliott C., Naegli H. Detection of hazardous food contaminations by transcriptomics fingerprinting. Trends Anal Chem 2011, 30:180-191.
19. Zacharewski R. In vitro bioassays for assessing estrogenic substances. Environ Sci Technol 1997, 31:613-623.
20. Petit F., Le Goff P., Cravédi J.-P., Valotaire Y., Pakdel F. Two complementary bioassays for screening the estrogenic potency of xenobiotics: recombinant yeast for trout estrogen receptor and trout hepatocyte cultures. J Mol Endocrinol 1997, 19:321-335.
21. Legler J., Zeinstra L., Schuitemarker F., Lanser P., Bogerd J., Brouwer A., et al. Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. Environ Sci Technol 2002, 31:4410-4415.
22. De Castro R., Korrick S., Spengler J., Soto A. Estrogenic activity of polychlorinated biphenyls present in human tissue and the environment. Environ Sci Technol 2006, 40:2819-2825.
23. Hamelers I., Van Schaik R., Sussenbach J., Steenbergh P. 17β-Estradiol responsiveness of MCF-7 laboratory strains is dependent on an autocrine signal activating the IGF type I receptor. Cancer Cell Int 2003, 3:10.
24. Shappell N. Estrogenic activity in the environment: municipal wastewater effluent, river, ponds and wetlands. J Environ Qual 2006, 35:122-132.
25. Nelson J., Bishay F., van Roo dselaar A., Ikonomou M., Law F. The use of in-vitro bioassays to quantify endocrine disrupting chemicals in municipal wastewater treatment plant effluents. Sci Total Environ 2007, 374:80-90.
26. Wang Z., Weber N., Lou Y., Proksch P. Prenylflavonoids as nonsteroidal phytoestrogens and related structure-activity relationships. ChemMedChem 2006, 1:482-488.
27. Benninghoff A. Toxicoproteomics-the next step in the evolution of environmental biomarkers?. Toxicol Sci 2007, 95:1-4.
28. Buterin T., Koch C., Naegeli H. Potential application of gene expression fingerprinting for food safety screening. Anal Chim Acta 2005, 529:33-39.
29. Malorni L., Cacace G., Cuccurullo M., Pocsfalvi G., Chambery A., Farina A., et al. Proteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17β-estradiol. Proteomics 2006, 6:5973-5982.
30. Lasserre J.P., Fack F., Revets D., Planchon S., Renaut J., Hoffmann L., et al. Effects of the endocrine disruptors atrazine and PCB 153 on the protein expression of MCF-7 human cells. J Proteome Res 2009, 8:5485-5496.
31. Legler J., van Brink C.-E., Brower A., Murk A.-J., van der Saag P.-T., Verthaak A.-D., et al. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 1999, 165:48-55.
32. Gorski K., Carneiro M., Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 1986, 47:767-776.
33. Mazzucchelli G., Gabelica V., Smargiasso N., Fléron M., Ashimwe W., Rosu F., et al. Proteome alteration induced by hTERT transfection of human fibroblast cells. Proteome Sci 2008, 6(12):1-13.
34. Berth M., Moser F., Kolbe M., Bernhardt J. The state of the art in the analysis of two-dimensional gel electrophoresis images. Appl Microbiol Biotechnol 2007, 76:1223-1243.
35. Perkins D., Pappin D., Creasy D., Cottrell J. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 18:3551-3567.
36. Blast http://www.expasy.ch/tools/blast/.
37. Shen Z., Li P., Ni, Ritchie M., Yang C.-P., Liu G.-F., et al. Label-free quantitative proteomics analysis of etiolated maize seedling leaves during greening. Mol Cell Proteomics 2009, 8:2443-2460.
38. Fleron M., Greffe Y., Musmeci D., Massart A.C., Hennequiere V., Mazzuchelli G., et al. Novel post-digest isotope coded protein labeling method for phosphor- and glycoproteome analysis. J Proteomics 2010, 1986-2005.
39. Fenyö D., Qin J., Chait B.T. Protein identification using mass spectrometric information. Electrophoresis 1998, 19:998-1005.
40. Krokhin O.V. Sequence-specific retention calculator. Algorithm for peptide retention prediction in ion-pair RP-HPLC: application to 300- and 100-A pore size C18 sorbents. Anal Chem Nov 15 2006, 78(22):7785-7795.
41. Kahn H., Presta A., Yang L., Blondal J., Trudeau M., Lickley L., et al. Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage. Breast Cancer Res Treat 2004, 86:237-247.
42. Kuang W., Thompson D., Hoch R., Weigel R. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res 1998, 26:1116-1123.
43. Chan R., Rossitto P., Edwards B., Cardiff R. Presence of proteolytically processed keratins in the culture medium of MCF-7 cells. Cancer Res 1986, 46:6353-6359.
44. Tedone T., Correale M., Paradiso A., Reshk S. Differential responsiveness of proliferation and cytokeratin release to stripped serum and oestrogen in the human breast cancer cell line, MCF-7. Eur J Cancer 1996, 5:849-856.
45. Kiang J., Tsokos G. Heat shock protein 70kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 1998, 80:183-201.
46. Kim K., Seo K., Kim Y., Park M., Park C., Kim P., et al. Estrogenic effects of phenolic compounds on glucose-6-phosphate dehydrogenase in MCF-7 cells and uterine glutathione peroxidase in rats. Chemosphere 2003, 50:1167-1173.
47. Sun Z., Zhu Y., Wang F., Chen R., Peng T., Fan Z., et al. Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers. Biochim Biophys Acta 2007, 1774:764-771.
48. Pereira-Leala J., Seabraa M. The mammalian Rab family of small GTPases: definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily. J Mol Biol 2000, 301:1077-1087.
49. Daikoku T., Tranguch S., Friedman D., Das S., Smith D., Dey S. From the cover: cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Mol Endocrinol 2004, 19:683-697.
50. Hubler T., Denny W., Valentine D., Cheung-Flynn J., Smith D., Scammell J. The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology 2003, 144:2380-2387.
51. Kumar P., Mark P., Ward B., Minchin R., Ratajczak T. Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem Biophys Res Commun 2001, 284:219-225.
52. Ovchinnikov L., Matuz L., Natapov P., Averbuch L., Wettenhall R., Szysha R., et al. Three phosphorylation sites in elongation factor 2. FEBS Lett 1990, 212:275-209.
53. Blake C., Brown L., Duncan M., Hunsucker S., Helmke S. Estrogen regulation of the rat anterior pituitary gland proteome. Exp Biol Med 2005, 230:800-807.
54. Parmer T., Ward M., Yurkow E., Vyas V., Kearney T., Hait W. Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer. Br J Cancer 1999, 79:59-64.
55. Sanders J., Maassen J., Moller W. Elongation factor-1 messenger-RNA levels in cultured cells are high compared to tissue and are not drastically affected further by oncogenic transformation. Nucleic Acids Res 1992, 22:5907-5910.
56. Mimori K., Mori M., Tanaka S., Akiyosh T., Sugimachi K. The overexpression of elongation factor 1 gamma mRNA in gastric carcinoma. Cancer Suppl 1995, 15:1446-1449.
57. Jensen L., Kuhn M., Stark M., Chaffron S., Creeveyn C., Muller J., et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009, 37:412-416.
58. Wang X., Yang Z., Zhang H., Ding L., Li X., Zhu C., et al. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT. Biochim Biophys Acta 2008, 1783:1220-1228.
59. Nair C., Toran J., Rimerman R., Hjermastad S., Smithgall T., Smith D. A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor Hsf1 and the aryl hydrocarbon receptor. Cell Stress Chaperones 1996, 1:237-250.
60. Böcker W., Hungermann D., Decker T. Anat Brustdrüse Pathol 2009, 30:6-12.
61. Shah Y., Basrur V., Rowan B. Selective estrogen receptor modulator regulated proteins in endometrial cancer cells. Mol Cell Endocrinol 2004, 219:127-139.
62. Limer J., Speirs V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res 2004, 6:119-127.
63. Dip R., Lenz S., Gmuender H., Naegeli H. Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol 2009, 47:787-795.